References
- Jopling W H. Complications of Treatment with Clofazimine (Lamprene: B663). Editorial. Lepr Rev 1976; 47: 1–3
- Moore V J. A review of side effects experienced by patients taking Clofazimine. Lepr Rev 1983; 54: 327–35
- ILEP communication. Information on side effects from Clofazimine (Lamprene, B663). Lepr Rev 1981; 52: 190
- Martindale W. Sulphones and other antileprotic agents. The Extra Pharmacopeia. 28th edn., JEF Reynolds. The Pharmaceutical Press, London 1982; 1488–9
- Browne S G, Hogerzeil L M. ‘B663’ in the treatment of leprosy. Preliminary report of a pilot trial. Lepr Rev 1962; 33: 6–10
- Levy L. Pharmacologic studies of Clofazimine. Am J Trop Med Hyg 1974; 23(6)1097–109
- Browne S G. B663 — possible anti-inflammatory action in leproma-tous leprosy. Lepr Rev 1965; 36: 9–11
- Anderson R. The immunopharmacology of antileprosy agents. Lepr Rev 1983; 54: 139–44
- Mansfield R E. Systemic tissue concentrations of clofazimine (B663). Am J Trop Med Hyg 1974; 23: 1116–9
- Desikan K V, Balakrishnan S. Tissue levels of clofazimine in a case of leprosy. Lepr Rev 1976; 47: 107–13
- Karat A BA. Long term follow up of Clofazimine (Lamprene) in the management of reactive phases of leprosy. Lepr Rev 1975; 46: 105–9, Suppl
- Plock H, Leiker D L. A long term trial with Clofazimine in reactive lepromatous leprosy. Lepr Rev 1976; 47: 25–34
- Meyer H, Hoigne R. Drugs used in tuberculosis and leprosy. Meyler's side effects of drugs. 10th edn. 1984; 31: 585–6
- Bryceson A. Unnecessary laparotomy for abdominal pain and fever due to Clofazimine. Lepr Rev 1979; 50: 258–9
- McDougall A C, Horsfall W R, Hede J E, Chaplin A J. Splenic infarction and tissue accumulation of crystals associated with the use of Clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum. Br J Derm 1980; 102: 227–30
- DeBergeyck E, Janssens P G, De Muynck A. Radiological abnormalities of the ileum associated with the use of clofazimine (Lamprene; B663) in the treatment of skin ulceration due to Mycobacterium ulcerans. Lepr Rev 1980; 51: 221–8
- Harvey R F, Harman R RM, Black C. Abdominal pain and malabsorption due to tissue deposition of Clofazimine (Lamprene) crystals. Br J Derm 1977; 97: 19, Suppl 15
- Desikan K V, Ramanujam K, Ramu G, Balakrishnan S. Autopsy findings in a case of lepromatous leprosy treated with Clofazimine. Lepr Rev 1975; 46: 181–9